Published in Proc Natl Acad Sci U S A on April 26, 2017
Number of people with glaucoma worldwide. Br J Ophthalmol (1996) 14.31
The optic nerve head as a biomechanical structure: a new paradigm for understanding the role of IOP-related stress and strain in the pathophysiology of glaucomatous optic nerve head damage. Prog Retin Eye Res (2005) 4.76
Complement regulators and inhibitory proteins. Nat Rev Immunol (2009) 4.46
Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. Proc Natl Acad Sci U S A (1995) 4.33
Genomic analysis of reactive astrogliosis. J Neurosci (2012) 3.62
Essential iris atrophy, pigment dispersion, and glaucoma in DBA/2J mice. Invest Ophthalmol Vis Sci (1998) 3.61
Axons of retinal ganglion cells are insulted in the optic nerve early in DBA/2J glaucoma. J Cell Biol (2007) 3.45
Mutations in genes encoding melanosomal proteins cause pigmentary glaucoma in DBA/2J mice. Nat Genet (2001) 3.30
Risk factors for incident open-angle glaucoma: the Barbados Eye Studies. Ophthalmology (2007) 3.24
Neuroinflammation in Alzheimer's disease. Lancet Neurol (2015) 3.02
Effect of intraocular pressure on rapid axoplasmic transport in monkey optic nerve. Invest Ophthalmol (1974) 2.91
Inherited glaucoma in DBA/2J mice: pertinent disease features for studying the neurodegeneration. Vis Neurosci (2005) 2.86
Susceptibility to neurodegeneration in a glaucoma is modified by Bax gene dosage. PLoS Genet (2005) 2.68
Retinal ganglion cells downregulate gene expression and lose their axons within the optic nerve head in a mouse glaucoma model. J Neurosci (2008) 2.56
Haploinsufficiency of the transcription factors FOXC1 and FOXC2 results in aberrant ocular development. Hum Mol Genet (2000) 2.32
Interacting loci cause severe iris atrophy and glaucoma in DBA/2J mice. Nat Genet (1999) 2.30
Molecular clustering identifies complement and endothelin induction as early events in a mouse model of glaucoma. J Clin Invest (2011) 2.25
Transcellular degradation of axonal mitochondria. Proc Natl Acad Sci U S A (2014) 2.15
Finite element modeling of optic nerve head biomechanics. Invest Ophthalmol Vis Sci (2004) 2.11
Reactive gliosis and the multicellular response to CNS damage and disease. Neuron (2014) 2.08
The dynamics and location of axonal transport blockade by acute intraocular pressure elevation in primate optic nerve. Invest Ophthalmol (1976) 1.97
Distal axonopathy with structural persistence in glaucomatous neurodegeneration. Proc Natl Acad Sci U S A (2010) 1.96
A biomechanical paradigm for axonal insult within the optic nerve head in aging and glaucoma. Exp Eye Res (2010) 1.85
Intraocular pressure in inbred mouse strains. Invest Ophthalmol Vis Sci (1997) 1.83
Complement C3 deficiency leads to accelerated amyloid beta plaque deposition and neurodegeneration and modulation of the microglia/macrophage phenotype in amyloid precursor protein transgenic mice. J Neurosci (2008) 1.78
Global changes in optic nerve head gene expression after exposure to elevated intraocular pressure in a rat glaucoma model. Invest Ophthalmol Vis Sci (2007) 1.73
Reduced retina microglial activation and improved optic nerve integrity with minocycline treatment in the DBA/2J mouse model of glaucoma. Invest Ophthalmol Vis Sci (2008) 1.69
Epidermal-growth-factor-dependent activation of the src-family kinases. Eur J Biochem (1994) 1.68
Absence of C1q leads to less neuropathology in transgenic mouse models of Alzheimer's disease. J Neurosci (2004) 1.66
Under pressure: cellular and molecular responses during glaucoma, a common neurodegeneration with axonopathy. Annu Rev Neurosci (2012) 1.65
Distribution of axonal transport blockade by acute intraocular pressure elevation in the primate optic nerve head. Invest Ophthalmol Vis Sci (1977) 1.51
Absence of glaucoma in DBA/2J mice homozygous for wild-type versions of Gpnmb and Tyrp1. BMC Genet (2007) 1.48
Myelination transition zone astrocytes are constitutively phagocytic and have synuclein dependent reactivity in glaucoma. Proc Natl Acad Sci U S A (2011) 1.47
Elevated epidermal growth factor receptor phosphorylation induces resistance artery dysfunction in diabetic db/db mice. Diabetes (2008) 1.45
Complement component 1Q (C1Q) upregulation in retina of murine, primate, and human glaucomatous eyes. Invest Ophthalmol Vis Sci (2006) 1.45
Radiation treatment inhibits monocyte entry into the optic nerve head and prevents neuronal damage in a mouse model of glaucoma. J Clin Invest (2012) 1.44
The mechanism of optic nerve damage in experimental acute intraocular pressure elevation. Invest Ophthalmol Vis Sci (1980) 1.39
Regulation by complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells. FASEB J (2003) 1.38
When ubiquitination meets phosphorylation: a systems biology perspective of EGFR/MAPK signalling. Cell Commun Signal (2013) 1.36
The pattern electroretinogram as a tool to monitor progressive retinal ganglion cell dysfunction in the DBA/2J mouse model of glaucoma. Invest Ophthalmol Vis Sci (2007) 1.35
IOP-dependent retinal ganglion cell dysfunction in glaucomatous DBA/2J mice. Invest Ophthalmol Vis Sci (2007) 1.30
Epidermal growth factor receptor activation: an upstream signal for transition of quiescent astrocytes into reactive astrocytes after neural injury. J Neurosci (2006) 1.29
Friend or foe? Resolving the impact of glial responses in glaucoma. J Glaucoma (2009) 1.27
The optic nerve head in glaucomatous optic neuropathy. Arch Ophthalmol (1997) 1.26
Oxidative stress and the regulation of complement activation in human glaucoma. Invest Ophthalmol Vis Sci (2010) 1.21
Neurodegeneration and inflammation in Parkinson's disease. Parkinsonism Relat Disord (2012) 1.19
Mechanisms of immune system activation in glaucoma: oxidative stress-stimulated antigen presentation by the retina and optic nerve head glia. Invest Ophthalmol Vis Sci (2007) 1.16
The complex role of neuroinflammation in glaucoma. Cold Spring Harb Perspect Med (2014) 1.13
Blockade of the epidermal growth factor receptor tyrosine kinase suppresses tumorigenesis in MMTV/Neu + MMTV/TGF-alpha bigenic mice. Proc Natl Acad Sci U S A (2000) 1.08
Preclinical analysis of the analinoquinazoline AG1478, a specific small molecule inhibitor of EGF receptor tyrosine kinase. Biochem Pharmacol (2006) 1.07
The immune response in glaucoma: a perspective on the roles of oxidative stress. Exp Eye Res (2010) 1.06
Effects of anti-glaucoma medications on ganglion cell survival: the DBA/2J mouse model. Vision Res (2002) 1.05
Network analysis of human glaucomatous optic nerve head astrocytes. BMC Med Genomics (2009) 1.03
Functional changes in the retina during and after acute intraocular pressure elevation in mice. Invest Ophthalmol Vis Sci (2009) 1.02
C1q--how many functions? How many receptors? Trends Cell Biol (1998) 0.99
Retinal ganglion cell dendritic atrophy in DBA/2J glaucoma. PLoS One (2013) 0.99
Deficiency of complement component 5 ameliorates glaucoma in DBA/2J mice. J Neuroinflammation (2013) 0.99
The C1q subunit of the first component of complement binds to laminin: a mechanism for the deposition and retention of immune complexes in basement membrane. Proc Natl Acad Sci U S A (1985) 0.99
T cell subsets and sIL-2R/IL-2 levels in patients with glaucoma. Am J Ophthalmol (2001) 0.97
Role of complement component C1q in the IgG-independent opsonophagocytosis of group B streptococcus. J Immunol (1999) 0.95
Activation of epidermal growth factor receptor signals induction of nitric oxide synthase-2 in human optic nerve head astrocytes in glaucomatous optic neuropathy. Neurobiol Dis (2003) 0.92
Heparin-binding epidermal growth factor-like growth factor signaling in flow-induced arterial remodeling. Circ Res (2008) 0.91
The paradoxical roles of C1q and C3 in autoimmunity. Immunobiology (2015) 0.88
Inhibition of the classical pathway of the complement cascade prevents early dendritic and synaptic degeneration in glaucoma. Mol Neurodegener (2016) 0.87
Activation of epidermal growth factor receptor causes astrocytes to form cribriform structures. Glia (2004) 0.87
The choreography of neuroinflammation in Huntington's disease. Trends Immunol (2015) 0.85
Chronic inhibition of epidermal growth factor receptor tyrosine kinase and extracellular signal-regulated kinases 1 and 2 (ERK1/2) augments vascular response to limb ischemia in type 2 diabetic mice. Am J Pathol (2011) 0.85
A neurobehavioral analysis of the prevention of visual impairment in the DBA/2J mouse model of glaucoma. Invest Ophthalmol Vis Sci (2012) 0.85
An LPA species (18:1 LPA) plays key roles in the self-amplification of spinal LPA production in the peripheral neuropathic pain model. Mol Pain (2013) 0.84
Transactivation of EGFR/PI3K/Akt involved in ATP-induced inflammatory protein expression and cell motility. J Cell Physiol (2012) 0.83
Adoptive transfer of immune cells from glaucomatous mice provokes retinal ganglion cell loss in recipients. Acta Neuropathol Commun (2015) 0.82
Protein-tyrosine phosphatase Shp2 positively regulates macrophage oxidative burst. J Biol Chem (2014) 0.81
Differential gene expression in glaucoma. Cold Spring Harb Perspect Med (2014) 0.81
Investigating the effect of ciliary body photodynamic therapy in a glaucoma mouse model. Invest Ophthalmol Vis Sci (2006) 0.81
Prevention of vision loss protects against age-related impairment in learning and memory performance in DBA/2J mice. Front Aging Neurosci (2013) 0.78
Mild stretch activates cPLA2 in alveolar type II epithelial cells independently through the MEK/ERK and PI3K pathways. Biochim Biophys Acta (2010) 0.76
Differential Effects of C1qa Ablation on Glaucomatous Damage in Two Sexes in DBA/2NNia Mice. PLoS One (2015) 0.75
TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer's disease mouse models. J Exp Med (2015) 1.88
JUN is important for ocular hypertension-induced retinal ganglion cell degeneration. Cell Death Dis (2017) 0.76
KLF9 and JNK3 Interact to Suppress Axon Regeneration in the Adult CNS. J Neurosci (2017) 0.75